Bayesian Capital Management’s Octave Specialty Group OSG Stock Holding History

Bayesian Capital Management’s Portfolio OSG Stock Details OSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,076	Closed	-$127K	–	591
2024 Q4	$127K	Buy	+10,076	New	+$121K	0.02%	603
2018 Q4	–	Sell	-14,634	Closed	-$299K	–	600
2018 Q3	$299K	Buy	14,634 +3,720	+34%	+$77.7K	0.05%	458
2018 Q2	$217K	Buy	+10,914	New	+$201K	0.05%	500
2017 Q1	–	Sell	-10,273	Closed	-$231K	–	396
2016 Q4	$231K	Buy	+10,273	New	+$224K	0.06%	482

Other funds holding OSG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return

Bayesian Capital Management's OSG Position: Q1 2025 in Review

Bayesian Capital Management sold out of Octave Specialty Group (OSG) in Q1 2025, closing a stake of 10,076 shares — an estimated $127K sold.

Bayesian Capital Management first reported a position in OSG in Q4 2016 and held it in 4 quarters. The position peaked at $299K in Q3 2018. 175 funds tracked by Wall St. Rank hold OSG as of Q1 2025.

Bayesian Capital Management reported no remaining Octave Specialty Group position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 10,076 Octave Specialty Group shares in Q1 2025, an estimated $127K.
Bayesian Capital Management first reported a position in Octave Specialty Group in Q4 2016 and held it in 4 quarters.
Bayesian Capital Management's Octave Specialty Group position peaked at $299K in Q3 2018.
175 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.